Table 1.
Clinical and metabolic characteristics of 5882 subjects with type 2 diabetes (T2D) and 2569 healthy controls in Chinese population.
Table 2.
Associations of single nucleotide polymorphisms (SNPs) of replicated genetic loci with type 2 diabetes and age at diagnosis in Chinese populations.
Figure 1.
Distributions and effects of unweighted (a–b) and weighted (c–d) CGSs on T2D risk.
Table 3.
Clinical features of subjects with type 2 diabetes (T2D) in each quartile of the unweighted (upper panel) and weighted (lower panel) combined genetic score (CGS), respectively.
Table 4.
Reclassification of predicted risk with the addition of unweighted combined genetic score (CGS) including 8 variants (P<0.05) in T2D subjects (upper panel) and healthy controls (lower panel).
Table 5.
Reclassification of predicted risk with the addition of weighted combined genetic score (CGS) including 8 variants (P<0.05) in T2D subjects (upper panel) and healthy controls (lower panel).